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Abstract
Protein expression in Escherichia coli represents the most facile approach for the preparation of non-glycosylated
proteins for analytical and preparative purposes. So far, the optimization of recombinant expression has largely
remained a matter of trial and error and has relied upon varying parameters, such as expression vector, media
composition, growth temperature and chaperone co-expression. Recently several new approaches for the genome-
scale engineering of E. coli to enhance recombinant protein expression have been developed. These
methodologies now enable the generation of optimized E. coli expression strains in a manner analogous to
metabolic engineering for the synthesis of low-molecular-weight compounds. In this review, we provide an
overview of strain engineering approaches useful for enhancing the expression of hard-to-produce proteins,
including heterologous membrane proteins.
Introduction
Since the beginning of the modern biotechnology era in
t h el a t e7 0 s ,Escherichia coli has been used extensively
for protein overexpression due to its rapid growth rate,
ease of high-cell-density fermentation, low cost and,
most importantly, the availability of excellent genetic
tools. The optimization of recombinant protein expres-
sion in E. coli has been carried out largely by trial and
error by varying simple parameters such as expression
vectors, host strains, media composition, and growth
temperature.
During the past years, extensive studies have shown
that the replacement of codons within a heterologous
gene with synonymous ones used preferentially in the
expression host (codon optimization), and the manipula-
tion of the nucleotide sequence of the translational initia-
tion region can have a profound effect on recombinant
protein yields [1-4]. mRNA secondary structures, RNase
cleavage sites and ribosome-binding site sequestering
sequences have been introduced into expression con-
structs in efforts to increase mRNA stability, improve
transcription termination and translation efficiency [5].
Currently, a wide selection of commercially available
expression vectors is provided with different origins of
replication, different promoters, translation initiation
regions, antibiotic resistance markers, transcription termi-
nators, etc. The selection of the proper vector together
with the use of codon-optimized genes [6,7] is in many
instances sufficient to enable the accumulation of the tar-
get protein at an appreciable level. This optimization
strategy, however, does not address problems related to
protein misfolding and solubility. Trial and error optimi-
zation of growth temperature, media optimization of
induction conditions, the use of fusions to solubilizing
partners and chaperone co-expression have to be
deployed to achieve better yields of biologically active
product. For example, fusions of the protein of interest
with partners, such as the maltose-binding protein (MBP)
or glutathione-S-transferase (GST) [8-10], as well as co-
expression of proteins that can assist in folding, notably
molecular chaperones/co-chaperones (GroEL/GroES,
DnaK/DnaJ etc) [11], are used routinely to increase solu-
ble protein yields. Nevertheless, there are many proteins
for which none of these approaches are effective.
Directed evolution of the polypeptide sequence for
improved synthesis and folding in a prokaryotic host, also
termed as “expression maturation”, has been employed
successfully for a variety of complex heterologous pro-
teins including mammalian G protein-coupled receptors
(GPCR), hemoglobin, antibody fragments and other
proteins [12-15]. In expression maturation, the gene
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any medium, provided the original work is properly cited.encoding the target protein is subjected to random muta-
genesis (e.g. by error-prone PCR), the library of mutant
genes is expressed, and variants with increased solubility
are identified, either by applying selective pressure or
by high-throughput screening [12-15]. The limitations of
this approach are first, that it lacks generality since it
needs to be applied for every individual protein target;
second, the need for a high-throughput screen for expres-
sion applicable to the protein of interest; and third, the
concern that the selected mutations may also affect the
function, stability, or the structure of the protein.
One alternative to expression maturation is to engineer
host strains that are suitable for the expression of parti-
cular classes of proteins, such as proteins with complex
disulfide topologies, membrane proteins, or proteins with
intrinsically slow folding kinetics, which, in general, are
more prone to misfolding and aggregation. The advan-
tage of this approach is its broader generality since it
leads to the generation of high-expression strains for a
variety of polypeptides that share some common features.
Furthermore, analysis of the chromosomal or vector
mutations that confer enhanced expression can provide a
better understanding of the rate limiting steps in protein
expression and perhaps be of general utility for the pro-
duction of other similar proteins.
Here, we will provide a review of current efforts to
enhance recombinant protein production in E. coli
through genetic and genome-scale engineering. Relevant
technologies for the creation and isolation of overex-
pressing mutants and successful examples of increased
protein yields are presented. The terms “genetic engi-
neering” and “strain engineering” are used interchange-
ably throughout this text.
Strain/genetic engineering for enhanced protein
expression in bacteria
Chromosomal lesions such as nucleotide substitutions,
gene deletions or insertions and, alternatively, overex-
pression of homologous or heterologous genes can all
influence the expression of target proteins. Genetic
modifications can be introduced into DNA in a targeted
manner within a specific cellular pathway known to be
involved in protein biogenesis. Alternatively, when the
causes of poor expression are not known, a library of
random chromosomal gene fragments can be cloned
and co-expressed with the target protein or, the entire
genome may be subjected to random mutagenesis,
followed by screening to isolate clones that confer
increased protein production.
1. Targeted strain engineering strategies
Targeted strain engineering focuses on the introduction
of mutations in DNA sequences known to affect protein
synthesis, degradation, secretion or folding. Several
excellent reviews describing the strategies for improving
protein secretion or for limiting protein degradation
have already been published [16-19]. Therefore, we will
focus here only on the engineering of bacterial strains
for improved protein synthesis and/or folding.
1.1 Engineering of mRNA stability and translational
efficiency
In bacteria, the half-life of mRNA is much shorter than
in eukaryotic cells and can be the rate limiting step in
translation and, hence, in protein synthesis. The endonu-
clease RNaseE catalyzes the first, rate-determining step in
the cleavage of numerous transcripts in E. coli.M u t a -
tions, such as the well characterized rne131 allele, that
attenuate the activity of this essential protein, confer
increased mRNA stability, which can in turn result in
higher protein expression levels [20]. A BL21 derivative
strain carrying the rne131 allele is commercially available
by Invitrogen under the brand name BL21 Star™.
As mentioned briefly above, translational efficiency
can be dramatically affected by codon usage and by the
sequence of the translation initiation region. Numerous
reports have demonstrated that the use of engineered
strains that co-express tRNAs for rare codons such as
the Rosetta™ strains from Invitrogen and the BL21
CodonPlus strains from Novagen can enhance recombi-
nant protein production significantly [21,22].
1.2 Improving protein folding by chaperone co-expression
A common, and occasionally successful, strategy for pre-
venting protein aggregation is the co-expression of
molecular chaperones. The biochemistry and mechan-
ism of action of bacterial molecular chaperones and
enzymes that assist folding have been reviewed pre-
viously [23], and will not be covered in detail here. It is
important to note that folding factors such as DnaK/
DnaJ/GrpE, GroEL/GroES, IbpA/IbpB, Skp, trigger fac-
tor and FkpA have been used successfully to prevent
protein aggregation of cytoplasmic or periplasmic pro-
teins [24-28]. The latter two proteins also display X-Pro
isomerization activity but their function in assisting pro-
tein folding has been attributed primarily to their role as
chaperones [29,30]. DnaK/DnaJ/GrpE, GroEL/GroES
and ClpB can function synergistically in assisting protein
folding and therefore expression of these chaperones
in combinations has been shown to be beneficial for
protein expression [11,31].
1.3 Expression of disulfide-bonded proteins
Many biotechnologically important proteins contain
disulfide bonds. The cytoplasm of E. coli is normally
maintained in a reduced state that precludes the forma-
tion of disulfide bonds via the action of the thioredoxin
and glutaredoxin/glutathio n ee n z y m es y s t e m s[ 3 2 ] .
Therefore, proteins with disulfides normally need to be
exported into the periplasm. In the periplasm, disulfide
bond formation and isomerization is catalyzed by the
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expression of the cysteine oxidase DsbA, the disulfide
isomerase DsbC or combinations of the Dsb proteins,
have been employed for the successful expression of
numerous heterologous proteins such as scFvs, plasmi-
nogen activators, human nerve growth factors and
others [25,33-35].
Mutant strains defective in glutathione reductase (gor)
or glutathione synthetase (gshA) together with thiore-
doxin reductase (trxB) render the cytoplasm oxidizing.
These strains are unable to reduce ribonucleotides and
therefore cannot grow in the absence of exogenous
reductant, such as dithiothreitol (DTT). Suppressor
mutations in the gene ahpC, which encodes the peroxir-
edoxin AhpC, allow the channeling of electrons onto
the enzyme ribonulceotide reductase enabling the cells
to grow in the absence of DTT. In such strains, exposed
protein cysteines become readily oxidized in a process
that is catalyzed by thioredoxins, in a reversal of their
physiological function, resulting in the formation of dis-
ulfide bonds. A number of heterologous multi-disulfide-
bonded proteins have been produced in the cytoplasm
of E. coli FA113 cells (trxB gor ahpC*)o rO r i g a m i ™
(Novagen) at high yields [36]. Additionally, it was
recently shown that bacterial strains with different
mutations in the thioredoxin/thioredoxin reductase and
glutaredoxin/glutathione reductase genes and containing
different suppressor mutations in alleles of ahpC, display
dramatic differences in the kinetics of cysteine oxidation
in the cytoplasm and in the yield of correctly folded
proteins [28,37].
Very recently, Ruddock and colleagues have shown
that overexpression of the sulfhydryl oxidase Erv1p from
the inner membrane space of yeast mitochondria
enables high-level production of a variety of complex,
disulfide-bonded proteins of eukaryotic origin in the
cytoplasm of E. coli [38]. Remarkably, these investigators
found that disulfide bond formation upon Erv1p co-
expression could take place even in the absence of trxB
gor mutations [39].
1.4 Glycoprotein production in E. coli
Until recently, protein glycosylation was considered a
post-translational modification which can only be car-
ried out in eukaryotes. In 2002, it was discovered that
the enteropathogenic bacterium Campylobacter jejuni
can perform protein N-glycosylation. Subsequent trans-
fer of the pgl locus led to the development of E. coli
strains which could perform N-glycosylation of the
C. jejuni proteins AcrA and PEB3 [40]. The pgl locus
consists of five putative glycosyltransferases (pglACHIJ),
an oligosaccharyl transferase (pglB), four enzymes
involved in sugar biosynthesis (galE, pglDEF), and a flip-
pase (wlaB) [41,42]. pglB mutants having relaxed specifi-
city have been engineered [41], thus opening the way
for the incorporation of diverse glycan structures onto a
target polypeptide. Furthermore, forward engineering
using shotgun proteomics and metabolic flux analysis
has been applied to significantly improve the efficiency
of protein glycosylation in E. coli [43]. Several groups
have started to utilize the C. jejuni pgl N-linked glycosy-
lation platform for biotechnological applications, includ-
ing the generation of glyco-conjugated vaccines in
bacteria [44,45]. Very recently, two groups have reported
the display of glycoproteins onto filamentous phage,
which in turn may enable the isolation of novel types of
glycoproteins from combinatorial libraries [46,47].
1.5 Acetylated protein production in E. coli
Acetylation is a very commonly encountered protein
modification, which is important for regulation in key
cellular processes [48,49]. In eukaryotes, most proteins
are acetylated at the alpha-amino group of the N-term-
inal amino acid or at the epsilon-amino group of inter-
nal lysines. In general, eukaryotic N-terminal acetylation
is carried out by specific N-a-acetyltransferase (Nat)
complexes and is thought to take place co-translation-
ally at the ribosome [50]. This protein modification,
however, is rarely encountered in bacteria, and in con-
trast to eukaryotes, it takes place in a post-translational
manner [51]. In a very recent study, overexpression of
the bacterial N-a-acetyltransferase RimJ was found to
be sufficient for the production of fully acetylated
recombinant thymosin alpha 1 in E. coli [52]. Even
more recently, Mulvihill and coworkers demonstrated
that co-expression of one of the members of the Nat
complex of the fission yeast (NatB) with its target sub-
strate proteins could successfully produce a number of
acetylated proteins of human and yeast origin in E. coli
[53]. These findings demonstrate that a wide variety of
acetylated proteins could be potentially produced
recombinantly in E. coli.
2. Global genetic/strain engineering
Strains that confer improved protein expression can be
engineered by screening libraries of chromosomal
mutants or plasmid-encoded expression libraries of het-
erologous or native genes. An important advantage of
this approach is that no a priori hypotheses or extensive
knowledge regarding bottlenecks in recombinant protein
expression is required. Identification and analysis of the
effects of the genetic lesions isolated in this process can
in turn provide a better understanding of the pathways
that limit the expression of the desired protein. The key
factors for successful strain engineering by library
screening approaches are: 1) the type of genetic modifi-
cation applied 2) the quality of the constructed library,
and 3) the availability of a high-throughput screen that
can correctly identify clones displaying the desired
phenotype.
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tributed over the entire chromosome can be readily gen-
erated by classical mutagenesis methods, such as UV
irradiation, chemical mutagens, and random transposon
mutagenesis. A very useful tool for studying the effect of
gene knockouts on recombinant protein expression and
other properties/phenotypes is the Keio collection, a
publicly available library of all single knockouts of all
the non-essential E. coli K-12 genes [54].
In addition to the classical mutagenesis strategies, new
techniques for genome engineering have been developed
recently for generating libraries in which the expression
of chromosomally encoded genes can been up- or down-
regulated. These techniques include global transcription
machinery engineering (gTME) [55] and trackable multi-
plex recombineering (TRMR) [56]. These and other gen-
ome engineering technologies may be employed to access
phenotypes that may be difficult to obtain via classical
mutagenesis approaches [57].
2.1 Strain engineering by classical mutagenesis
One of the most frequently encountered phenotypic
consequences of recombinant protein expression is
growth retardation or complete growth arrest of the
host following induction of gene overexpression. More
than a decade ago, Walker and coworkers isolated
E. coli BL21(DE3) mutant strains carrying spontaneously
acquired suppressor mutations that alleviate the toxicity
caused by the production of cytotoxic proteins under
the control of the strong T7 promoter [58]. These
strains, which are called C41 and C43 or “Walker
strains”, are widely used to produce increased levels of
hard-to-express proteins primarily because they allow
increased biomass production. Not surprisingly, it was
later found that the mutations in these strains reduce
the translational efficiency of the T7 RNA polymerase
[59]. C41 and C43 are currently commercially available
by Avidis.
Recently, Bowie and co-workers used a combination of
the mutagenic base analog 2-aminopurine and the
mutator gene mutD5 (a mutated dnaQ gene causing a
DNA proofreading defect), to evolve E. coli strains
which accumulate markedly enhanced amounts of a
variety of different Mycobacterium tuberculosis rhom-
boid family proteins and other prokaryotic and eukaryo-
tic integral membrane proteins [60]. These strains were
found to produce up to 90-fold higher amounts of pro-
tein compared to the parental strain TOP10. In an ana-
logous manner, our group has used the chemical
mutagen N-methyl-N’-nitro-N-nitrosoguanidine to gen-
erate E. coli mutants that confer up to 5-fold greater
yields of properly assembled full-length IgG antibodies
in the bacterial periplasm [61]. In another example of
classical strain mutagenesis for enhanced recombi-
nant protein production, Skretas and Georgiou used
insertional mutagenesis of the Tn5 transposon together
with fluorescence-activated cell sorting (FACS), to iso-
late E. coli MC4100A variants that accumulate increased
amounts of the membrane-inserted human GPCR cen-
tral cannabinoid receptor (CB1) [62].
Genes, gene fragments or operon fragments that
favorably affect protein expression can be isolated from
plasmid libraries co-expressing genomic fragments.
Alternatively, individual intact genes can be identified
using the ASKA library, an ordered library of all the
E. coli ORFs transcribed from the inducible T5lac pro-
moter [63]. Using this library, our group identified
E. coli proteins that enhanced the yields of the mem-
brane-embedded form of the human GPCR bradykinin
receptor 2 (BR2) [64]. One of these, the putative DNA-
binding protein of unknown function YbaB, conferred a
~10-fold increase in the accumulation of membrane-
integrated and folded BR2, as well as a variety of mem-
brane proteins tested of either prokaryotic or eukaryotic
origin.
The described genetic engineering strategies for
enhancing recombinant protein production in bacteria
are summarized in Table 1.
2.2 Genome engineering
Genome engineering techniques refer loosely to a group
of methods for introducing desired genetic diversity
within known regions of the chromosome. Modifying
the transcriptional landscape of E. coli, e.g. by generat-
ing libraries of randomized transcription factors or by
mutating components of the RNA polymerase, is an
effective means of generating complex phenotypes.
Although genome engineering has not yet been applied
extensively to the optimization of recombinant protein
expression, it holds great promise for the creation of the
next generation of E. coli host strains for protein pro-
duction. The great advantage of these methods is that
they can have a global impact on cellular pathways and
physiology [65]. Examples of genome engineering meth-
ods likely to be of particular interest for expression opti-
mization are outlined below and summarized in Table 2.
Global transcription machinery engineering (gTME) is
a new tool that enables the reprogramming of the cellu-
lar transcriptome through random mutagenesis (e.g. by
error-prone PCR) of selected components of the tran-
scriptional machinery, such as the E. coli sigma factor
s
70, the a subunit of the E. coli RNA polymerase, or the
S. cerevisiae TATA-binding transcription factor Spt15p.
Screening of plasmid-encoded gTME libraries was used
to isolate strains with increased tolerance to alcohols
and for enhanced production of small molecules, such
as lycopene (50% increase), L-tyrosine (150% increase),
hyaluronic acid (60% increase), and others [55,66-68].
Zinc fingers are highly specific DNA-binding protein
domains that recognize three-base-pair sequences and
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teins. A single transcription factor can include several of
these motifs, which can be assembled in a highly modu-
lar fashion to target loner motifs and confer sequence
selectivity. Fusions of random combinations of zinc fin-
gers with activator or repressor domains have been
employed to introduce high levels of diversification of
transcription, which in turn can generate diverse com-
plex phenotypes, such as tolerance to high and low tem-
peratures, drug resistance, osmotic tolerance, and
differentiation in different organisms, such as Saccharo-
myces cerevisiae, mammalian cells, and E. coli [69-71].
Such libraries of random combinations of zinc fingers
can potentially be used to generate engineered bacterial
strains, whose evolved transcriptome affects favorably
recombinant protein production.
Very recently, Gill and co-workers have developed a
creative methodology, termed trackable multiplex recom-
bineering (TRMR), for constructing libraries of geneti-
cally modified microorganisms based on homologous
Table 1 Genetic engineering strategies which have been applied to the enhancement of recombinant protein
production in bacteria
Method Strain Target protein Reference
Spontaneous chromosomal
mutagenesis
C(1(DE3), C43(DE3) Bovine OGCP; bovine phosphate carrier; bovine ADP/ATP
translocase; Bacillus subtilis PS3 alanine/H
+ carrier; E. coli
F-ATPase subunits b and c; bovine F-ATPase subunits b, d,
a, b, g, δ, OSCP, F6; bovine F-ATPase inhibitor protein;
Aequoria victoria GFP
[58]
Chromosomal mutagenesis
using chemical mutagens or
mutator genes
EXP-Rv1337-1, EXP-Rv1337-2, EXP-Rv1337-3,
EXP-Rv1337-4, EXP-Rv1337-5
Mycobacterium tuberculosis Rv1337, M. tuberculosis Rv2746,
M. tuberculosis Rv2835, M. tuberculosis Rv0110,
Methanocccus jannaschii rhomboid (MJR), Drosophila
melanogaster rhomboid 1 (Rho1)
[60]
GS1, TM1, TM2, TM3, TM4, TM5, TM6 Variants of human IgG1 [61]
Transposon mutagenesis GS101 (MC4100A dnaJ349::Tn5 (Kan
R))
GS102 (MC4100A dinG1377::Tn5 (Kan
R))
GS103 (MC4100A nhaR63::Tn5 (Kan
R))
GS104 (MC4100A ΔdinG)
GS105 (MC4100A ΔdinG dnaJ349::Tn5 (Kan
R))
Human central cannabinoid receptor (CB1) [62]
Co-expression of the ASKA
library
MC4100A (+ybaB)
MC4100A (+yciQ)
MC4100A (+glpQ)*
Human bradykinin receptor 2 (BR2), CB1, human neurokinin
(substance P) receptor 1 (NKR1), E. coli YidC, E. coli CstA,
human stearoyl-CoA desaturase (SCD)
[64]
*MC 100A (+name of gene) denotes an MC 100 strain overexpressing the E. coli gene specified in parentheses.
Table 2 Representative genome engineering strategies which could be applied to the enhancement of recombinant
protein production in bacteria
Method Targeted cellular component Target organism Engineered phenotype References
Global transcription
machinery
engineering (gTME)
General sigma factor s
70, stationary
phase sigma factor s
S, RNA
polymerase a subunit
E. coli Ethanol, butanol, isobutanol, pentanol, and 3-
pentanol tolerance; lycopene, L-tyrosine, and
hyaluronic acid production
[55,66,68]
Transcription factor Spt15p S. cerevisiae Ethanol tolerance and production [67]
General sigma factor Lactobacillus
plantarum
lactic acid and hydrochloric acid tolerance [95]
Libraries of artificial
zinc fingers
Zinc fingers S. cerevisiae Tolerance to heat and osmotic stress;
ketoconazole resistance
[69]
Mouse neuroblastoma
cells
Neurogenesis, differentiation of neuroblasts to
osteoblasts, proliferation rate
[69]
E. coli Tolerance to heat, cold, and osmotic stress [70,71]
Trackable multiplex
recombineering
(TRMR)
> 95% of all individual E. coli genes E. coli Tolerance to salicin, D-fucose, methylglyoxal,
valine, and lignocellulosic hydrolysate
[56]
Genome shuffling Chromosome Streptomyces fradiae Tylosin production [72]
A strain of
Lactobacillus
Tolerance to lactic acid [73]
Sphingobium
chlorophenolicum
Degradation of pentachlorophenol [74]
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two sets of oligoDNA cassettes were synthesized: Each
contained 5’ and 3’ recognition sequences for homolo-
gous recombination of the ribosome-binding site (RBS) of
each one of the 4,077 protein-coding genes of E. coli
MG1655, interrupted by a gene-specific tracking
sequence, an antibiotic resistance marker for selection
of successful recombination, and an “up cassette” or
a “down cassette”.T h e“up cassette” contained the
sequences of the strong inducible promoter PLtetO-1 with
a RBS, whose function was to generally up-regulate the
expression of its target gene, while the “down cassette”
contained an inert sequence, whose function was to gen-
erally down-regulate gene expression. Homologous
recombination of these oligonucleotides enabled the crea-
tion of pools of bacteria displaying upregulation or down-
regulation of genes at a genomic scale. The library of the
mutant strains (2 × 4,077 = 8,154 total) was subsequently
subjected to selection for growth under various condi-
tions. Using this approach, Warner et al. reported the iso-
lation of thousands of clones with improved growth
phenotype in various conditions within a week [56]. The
isolated clones could be easily characterized by sequen-
cing or by microarray analysis using the recombined tag
sequences to identify the genes responsible for the evolu-
tion of these complex phenotypes. However, it is not
clear yet if the TRMR libraries of bacterial cells with up-
and down-regulated genes will enable the evolution of
novel traits which are different than those achieved with
the use of the ASKA library and the Keio collection,
respectively.
Once a collection of strains displaying increased
expression has been created by one of the techniques
discussed so far, whole genome recombination or “shuf-
fling” may be employed to create a library of clones con-
taining combinations of alleles that contribute to better
expression. Strains containing combination of alleles
that act synergistically can then be isolated [72]. Conse-
cutive rounds of genome shuffling have been shown to
result in the rapid emergence of complex phenotypes
in a variety of microorganisms, such as a nine-fold
improvement of tylosin production in Streptomyces fra-
diae, a three-fold increase in lactic acid production in a
poorly characterized industrial strain of Lactobacillus,
and a dramatically enhanced ability to degrade the
anthropogenic pesticide pentachlorophenol in Sphingo-
bium chlorophenolicum [72-74]. Genome shuffling in
E. coli, however, is rather inefficient [75] and, therefore,
new techniques will have to be developed before this
methodology becomes routine for this organism.
2.3 Screening/Selection platform
An important issue in the engineering of novel strains
for improved expression is how to monitor the yield of
the desired protein in a high-throughput manner. For
small libraries, microtiter well plates can be used to
screen up to a few thousand clones. Immunoassays,
namely enzyme-linked immunosorbent assays (ELISAs)
and 96-well Western blot analyses can be used to quan-
tify the level of soluble protein when no functional assay
is available. However, screening of libraries sizes exceed-
ing ~10
5 clones requires the use of single-cell assay for-
mats [76]. Designing the appropriate selection or
screening process for the isolation of clones with the
desired phenotypes is a key factor for the implementa-
tion of genome engineering strategies for enhanced
recombinant protein production. A number of high-
throughput selection/screening systems have been
developed and/or utilized in the past few years for the
development of such overexpressing strains.
2.3.1 Genetic selection The levels of accumulation of a
protein of interest can be coupled with the growth of
the host cell under selective conditions by expressing
the target protein in the form of a chimeric fusion with
a reporter protein which exhibits a selectable phenotype,
such as an antibiotic resistance marker. Bowie and
coworkers, for example, isolated E. coli strains with
enhanced capacity for integral membrane protein
expression by selecting for antibiotic resistance con-
ferred by expressing two separate C-terminal fusions of
the M. tuberculosis rhomboid membrane protein
Rv1337 to chroramphenicol acetyltransferase (the
enzyme conferring resistance to the antibiotic chloram-
phenicol) or aminoglycoside 3’-phosphotransferase (the
enzyme conferring resistance to the antibiotic kanamy-
cin) [60]. Our group has developed a simple genetic
selection system for enhanced recombinant membrane
protein production in E. coli, by utilizing a tripartite
fusion comprising the human GPCR BR2 with an N-
terminal DsbA leader sequence, which targets the
recombinant protein to the signal recognition particle
pathway for insertion into the bacterial inner membrane,
and a C-terminal b-lactamase [64]. A number of similar
approaches have been developed using chloramphenicol
acetyltransferase [77,78] and dihydrofolate reductase
(DHFR) [79], or combinations of these [80] as fusion
reporter proteins.
Recently, protein fragment complementation assays
were developed especially for monitoring protein folding
and expression. In this systems, the protein of interest is
inserted into the middle of a reporter gene, such as
b-gatactosidase [81], b-lactamase [82], or GFP [83-85].
Since the activity of the reporter is designed to be
recovered only when the correct folding of the test pro-
tein has occurred, its activity is proportional to the level
of accumulation of correctly folded protein in the cell.
Recently, DeLisa and colleagues developed a novel
selection platform for protein folding, by capitalizing on
the properties of the bacterial twin-arginine translocation
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independent inner membrane transport system that is
known for its ability to transport only proteins that have
undergone folding before translocation [87]. In this sys-
tem, a protein of interest is inserted between an N-term-
inal Tat signal peptide and a C-terminal b-lactamase
enzyme. Since b-lactamase is active when it is exported
into the periplasm, only cells with correctly folded target
protein can survive on antibiotic-containing selective
media.
2.3.2. High-throughput screening using fluorescent
reporters Since the original observation by Waldo and
co-workers that the fluorescence of E. coli cells expres-
sing a C-terminal fusion of a recombinant protein with
the green fluorescent protein (GFP) correlates well with
the expression levels of well folded and soluble protein
[88], fluorescent proteins have been widely used to
monitor the expression level for both soluble and mem-
brane-embedded proteins [7,62,89,90]. Microplates using
a fluorescence plate reader, dot blot analyses using a
fluorescence scanner, or flow cytometry are routinely
used for monitoring the fluorescence of GFP fusions
[91-93]. Flow cytometry is by far the most powerful tool
for fluorescence-based library screening in terms of
throughput, ability to monitor fluorescence at the sin-
gle-cell level in a quantitative manner, and the isolation
of desired clones [7,62,76,89].
The accumulation of active, secreted protein at the sin-
gle-cell level can be readily monitored by periplasmic
expression followed by cytometric sorting (PECS) [94]. In
this technique, E. coli cells expressing a protein in the
periplasm are incubated in a high-osmolarity buffer that
renders their outer membrane permeable to a ligand
labeled with a fluorescent probe (Figure 1) [94]. The
fluorescent ligand binds to the properly folded protein,
conferring cell fluorescence proportional to the amount
of functional protein in the periplasm. Clones containing
mutations that increase the expression of functional pro-
tein, display higher fluorescence and can be isolated by
FACS. By using this technique, we have isolated several
E. coli mutant strains which accumulate markedly
enhanced quantities of full-length and properly assembled
Figure 1 Periplasmic expression with cytometric sorting (PECS) for enhanced recombinant protein expression. E. coli cells expressing the
protein of interest in the periplasm are incubated in a high-osmolarity buffer that renders their outer membrane permeable to a fluorescently
labeled ligand. Cell fluorescence is proportional to the number of functional, ligand-binding molecules in the periplasm. Clones containing
genetic lesions that increase protein expression, display higher fluorescence and can be rapidly isolated using FACS. Adapted from Makino et al.
[61].
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more, we have utilized PECS to isolate several genes and
gene clusters which confer high expression levels of prop-
erly folded integral membrane proteins, including several
mammalian GPCRs and native bacterial membrane pro-
teins [GS, TM, Navin Varadarajan, Mark Pogson, and
GG; manuscript in preparation].
Conclusion
Recent studies have demonstrated that strain/genetic
engineering is a very promising approach for evolving
engineered E. coli strains with markedly enhanced capa-
cities for recombinant protein production. Several
unique and powerful methods have emerged recently
that allow the generation of large libraries of bacterial
mutants carrying different types of genetic profiles.
Furthermore, advances in high-throughput screening
have enabled the monitoring of the overexpression phe-
notype at the single-cell level and the rapid isolation of
the rare clones with the desired overexpression profiles.
The information obtained from the analysis of the
genetic profiles in the isolated strains can provide
invaluable and fundamental understanding about the
biology of protein biogenesis, folding, stability and
homeostasis in bacteria. These pieces of information can
subsequently be combined and utilized to generate spe-
cialized protein expression bacterial “cell factories” for
uses in research as well as in the industrial field.
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